Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia?

被引:49
作者
Steensma, DP
Dewald, GW
Hodnefield, JM
Tefferi, A
Hanson, CA
机构
[1] Mayo Clin & Mayo Fdn, Div Hematol, Dept Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Div Lab Genet, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[3] Mayo Clin, Div Hematopathol, Dept Parasitol & Lab Practice, Rochester, MN 55905 USA
关键词
myelodysplasia; cytogenetics; bone marrow morphology; cytopenias;
D O I
10.1016/S0145-2126(02)00161-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cytogenetic abnormalities suggestive of a myeloid disorder are occasionally observed in the bone marrow (BM) cells of patients with morphologically and immunohistochemically unremarkable marrow aspirates and biopsies. Between 1994 and 2000,55 such patients were seen at our institution (34 men; median age of 66 years). The indications for BM sampling included unexplained cytopenias (31 patients), staging or follow-up of a lymphoproliferative disorder or a plasma cell dyscrasia (18 patients), or another miscellaneous reason (6 patients). Specific cytogenetic abnormalities included a 20q deletion or monosomy 20 (10 patients), a chromosome 7 deletion (8 patients), +8 (5 patients), del(5q) or a 5q translocation (4 patients), and del(13q) (2 patients). Eleven patients had a complex karyotype. As of January 2002, 23 of the 55 patients were dead; median follow-up for living patients is 20 months. Of the 23 dead patients, I died of acute myelogenous leukemia (AML) and 6 of complications related to cytopenias. This study provides support for obtaining cytogenetic studies in patients with unexplained cytopenias if a morphologic explanation for the cytopenias is lacking. Continued follow-up of this heterogeneous cohort and further studies of similar patients will more clearly define the disease processes and prognosis for this constellation of laboratory findings. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:235 / 242
页数:8
相关论文
共 77 条
  • [1] Abruzzese E, 1999, BLOOD, V94, P1814
  • [2] APPELBAUM FR, 1987, EXP HEMATOL, V15, P1134
  • [3] Involvement of MLL gene in a t(10;11)(q22;q23) and a t(8;11)(q24;q23) identified by fluorescence in situ hybridization
    Aventín, A
    La Starza, R
    Martínez, C
    Wlodarska, I
    Boogaerts, M
    Van den Berghe, H
    Mecucci, C
    [J]. CANCER GENETICS AND CYTOGENETICS, 1999, 108 (01) : 48 - 52
  • [4] Myelodysplastic syndrome and aplastic anemia - diagnostic and conceptual uncertainties
    Barrett, J
    [J]. LEUKEMIA RESEARCH, 2000, 24 (07) : 595 - 596
  • [5] Trisomy 15 is frequently observed as a minor clone in patients with anemia/MDS/NHL and as a major clone in patients with AML
    Batanian, JR
    Slovak, ML
    Mohamed, A
    Dobin, S
    Luthardt, FW
    Keitges, EA
    [J]. CANCER GENETICS AND CYTOGENETICS, 2000, 121 (02) : 186 - 189
  • [6] CYTOGENETIC STUDIES IN 18 PATIENTS WITH SECONDARY BLOOD DISORDERS
    BENITEZ, J
    CARBONELL, F
    FERRO, T
    PRIETO, F
    FAYOS, JS
    [J]. CANCER GENETICS AND CYTOGENETICS, 1986, 22 (04) : 309 - 317
  • [7] BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x
  • [8] Rare recurring balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and acute leukemia: Report from an international workshop
    Block, AW
    Carroll, AJ
    Hagemeijer, A
    Michaux, L
    van Lom, K
    Olney, HJ
    Baer, MR
    [J]. GENES CHROMOSOMES & CANCER, 2002, 33 (04) : 401 - 412
  • [9] A group of previously not recognized cytogenetic abnormalities in myeloid hematological malignancies
    Chen, Z
    Richkind, K
    Roherty, S
    Velasco, J
    Lytle, C
    Brothman, AR
    Sandberg, AA
    [J]. CANCER GENETICS AND CYTOGENETICS, 1999, 113 (02) : 162 - 165
  • [10] HEMATOLOGIC MANIFESTATIONS ASSOCIATED WITH DELETIONS OF THE LONG ARM OF CHROMOSOME-20
    DAVIS, MP
    DEWALD, GW
    PIERRE, RV
    HOAGLAND, HC
    [J]. CANCER GENETICS AND CYTOGENETICS, 1984, 12 (01) : 63 - 71